You just read:

NICE Recommends Amgen's BLINCYTO® ▼ (Blinatumomab) for Adults With Relapsed or Refractory Philadelphia Chromosome-Negative B-Precursor Acute Lymphoblastic Leukaemia

News provided by

Amgen

27 Apr, 2017, 15:33 BST